Midazolam and Enterobacter infection - a phase IV clinical study of FDA data

Summary:

Enterobacter infection is reported as a side effect among people who take Midazolam (midazolam), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Dexamethasone, and have Small cell lung cancer extensive stage.

The phase IV clinical study analyzes which people have Enterobacter infection when taking Midazolam. It is created by eHealthMe based on reports of 11,245 people who have side effects when taking Midazolam from the FDA, and is updated regularly.

What is Midazolam?

Midazolam has active ingredients of midazolam. eHealthMe is studying from 11,246 Midazolam users. Check the latest studies of Midazolam.

What is Enterobacter infection?

Enterobacter infection (infection caused by bacteria of the family enterobacteriaceae) is found to be associated with 266 drugs and 554 conditions by eHealthMe. Check the latest studies of Enterobacter infection.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

11,245 people reported to have side effects when taking Midazolam.
Among them, 16 people (0.14%) have Enterobacter infection.

Could Midazolam cause Enterobacter infection?

Among these 16 people:

How long have people been on Midazolam when they have Enterobacter infection? *

What is the gender of people who have Enterobacter infection when taking Midazolam? *

female: 0.0 %
male: 100 %

What is the age of people who have Enterobacter infection when taking Midazolam? *

What are other drugs people take besides Midazolam? *

What are other side effects people have besides Enterobacter infection? *

Dyspnea (difficult or laboured breathing): 4 people, 25.00%
Oedema Peripheral (superficial swelling): 4 people, 25.00%
Constipation: 4 people, 25.00%
Coughing Up Blood: 4 people, 25.00%
Escherichia Infection (bacterial infection by escherichia coli): 4 people, 25.00%
Back Pain: 4 people, 25.00%
Limb Injury: 4 people, 25.00%
Pulmonary Embolism (blockage of the main artery of the lung): 4 people, 25.00%
Septic Shock (shock due to blood infection): 4 people, 25.00%
Transaminases Increased: 4 people, 25.00%

What are the existing conditions these people have? *

Small Cell Lung Cancer Extensive Stage (small cell lung cancer that has spread (metastasized) to other regions of the body such as another lobe of the lung or the brain): 4 people, 25.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 18.75%
Embolism Venous (embolus may pass into the arterial system): 3 people, 18.75%
Glaucoma (increased fluid pressure in the eye with vision loss): 3 people, 18.75%
Hyperkalemia (damage to or disease of the kidney): 3 people, 18.75%
Stress And Anxiety: 3 people, 18.75%
Hypoglycemia (low blood sugar): 3 people, 18.75%
Enlarged Prostate: 3 people, 18.75%
Gastric Ulcer (stomach ulcer): 3 people, 18.75%
Bacterial Infection: 3 people, 18.75%

* Approximation only. Some reports may have incomplete information.

Do you take Midazolam and have Enterobacter infection?

- Check whether Enterobacter infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Midazolam:

Midazolam (11,246 reports)

Browse all side effects of Midazolam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Enterobacter infection:

Enterobacter infection (266 drugs)

Browse all the conditions that are associated with Enterobacter infection:

Enterobacter infection (554 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on midazolam (the active ingredients of Midazolam) and Midazolam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.